Patents Represented by Attorney Catalyst Law Group
-
Patent number: 7794224Abstract: A continuous production system for fabricating composite articles from a moldable material includes, in an exemplary embodiment, a pair of opposed closed loop cleated belt conveyors spaced apart a predetermined distance. Each cleated belt includes a plurality of cleats, and each cleat includes a notch. The forming system also includes a pair of opposed endless profile mold belts positioned at least partially between the pair of cleated belts. The mold belts are located at least partially in the notches of the cleats.Type: GrantFiled: September 28, 2004Date of Patent: September 14, 2010Assignee: Woodbridge CorporationInventor: Edward John Butteriss
-
Patent number: 7728153Abstract: The present invention features methods of treating a cancer in a subject by administering an effective amount of a beta-lactone to the subject. The invention also features methods of inhibiting angiogenesis in a subject by administering an effective amount of an inhibitor of fatty acid synthase to the subject. These methods can be used to treat a variety of cancers and other diseases and conditions. The invention also features methods of identifying beta-lactones and other compounds that can be used in the methods of the invention for the treatment of tumors, inhibition of angiogenesis, and the treatment of diseases and conditions that involve pathological angiogenesis. The invention also features methods of synthesizing beta-lactones and features novel beta-lactone compounds.Type: GrantFiled: March 16, 2006Date of Patent: June 1, 2010Assignee: The Burnham Institute for Medical ResearchInventors: Jeffrey W. Smith, Fumiko Axelrod, Steven J. Kridel, Daniel Romo, Vikram Purohit, Gil Ma
-
Patent number: 7622614Abstract: The present invention is directed to novel methods for production of 5-epi-?-vetivone, 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-2,6-dien-8-one and 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-1,6-dien-8-one, which are useful for their fragrant qualities. In one embodiment the present invention describes a method for production of 5-epi-?-vetivone by the use of premnaspirodiene as starting material. In another embodiment the present invention describes a method for production of 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-2,6-dien-8-one and 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-1,6-dien-8-one by the use of premnaspirodiene as starting material. In yet another embodiment the present invention describes a novel method for production of premnaspirodiene from a terpene substrate.Type: GrantFiled: March 20, 2008Date of Patent: November 24, 2009Assignee: Allylix, Inc.Inventors: Bryan N. Julien, David M. Wallace
-
Patent number: 7597911Abstract: A selection of herbal materials with curative effects combined in a liquid form and processed into a suitable topical delivery system for application to skin ulcerations, surgical incisions wounds and cuts to accomplish accelerated wound healing. The present invention can also heal and provide 1st and 2nd degree burn, radiation burn and sunburn relief and be used for application to human skin affected with psoriasis, eczema, dermatitis, acne, rosacea, extreme dryness, allergic reactions and inflammatory rashes. The process to manufacture and the herbal extract vehicle of delivery are both critical to the effectiveness of the present invention since the invention is comprised of two separate herbal composition extracts which do not form a homogenous mixture when combined.Type: GrantFiled: August 16, 2002Date of Patent: October 6, 2009Assignee: CuraPharm, Inc.Inventor: Thomas M. Hnat
-
Patent number: 7597652Abstract: Systems and techniques to mount equipment in a watertight fashion to a wall. A watertight mount includes a mounting base including a flange and a socket having an interior surface including mating threads. The mount may include a base plate coupled with the mounting base, the base plate defining an opening through which the socket passes. The mount may also include a gasket coupled between the base plate and the mounting base, the gasket defining an opening through which the socket passes, and the base plate may be releasably coupled with the mounting base through a spa wall. The base plate may be coupled with the mounting base using a connector, such as a nut defining a threaded hole that matches securing threads on an exterior surface of a barrel shaped socket in the mounting base.Type: GrantFiled: August 1, 2002Date of Patent: October 6, 2009Assignee: Dimension One SpasInventors: Victor Lee Walker, Angelo Vito Pugliese, Jr., James Donald McClure, Jr.
-
Patent number: 7544478Abstract: Discovered is a novel protein and variants thereof whose activity at the NMDA receptor causes an increased efflux of calcium ions through the channel of said receptor. This activity is downregulated by the NR3A subunit of NMDA. Also discovered are the nucleic acid sequences encoding said novel protein and variants thereof. The discovery is useful for the diagnosing of NMDA receptor dysregulation and the treatment of NMDA receptor dysregulation related disorders. In addition, the discovery is useful for the further discovery of modulators affecting the activity of the novel protein and variants thereof at the NMDA receptor.Type: GrantFiled: August 9, 2004Date of Patent: June 9, 2009Assignee: The Burnham InstituteInventors: Nobuki Nakanishi, Gang Tong, Shichun Tu
-
Patent number: 7528175Abstract: The use of ?-adrenergic inverse agonists provides a new and highly efficient way of treating a number of pulmonary airway diseases, including asthma, emphysema, and chronic obstructive pulmonary diseases. In general, such a method involves administering a therapeutically effective amount of a ?-adrenergic inverse agonist to the subject to treat the pulmonary airway disease. Particularly preferred inverse agonists include nadolol and carvedilol. In addition, methods are described for long-tern administration of such inverse agonists and for determining the suitability of patients for long-term inverse agonist therapy.Type: GrantFiled: October 7, 2005Date of Patent: May 5, 2009Assignee: Inverseon, Inc.Inventor: Richard A. Bond
-
Patent number: 7521548Abstract: A novel human member of the Bcl-2 family Bcl-B has been identified, which is closest in amino-acid sequence homology to the Boo (Diva) protein. The Bcl-B protein is widely expressed in adult human tissues. The Bcl-B protein modulates apoptosis. Bcl-B also binds Bcl-2, BCI-XL, and Bax but not Bak. Bcl-B displays a unique pattern of selectivity for binding and regulating the function of other members of the Bcl-2 family.Type: GrantFiled: February 7, 2002Date of Patent: April 21, 2009Assignee: Burnham Institute for Medical ResearchInventors: John C. Reed, Ning Ke, Adam Godzik
-
Patent number: 7504205Abstract: The present invention relates to novel methods for identifying antiviral agents which selectively interfere with viral proteins that cause the unique infectivity activity of the SARS-coronavirus in comparison to other non-SARS strains of coronavirus. In particular, the present invention relates to screening assays that identify agents which selectively inhibit cyclic-AMP dependent protein kinase activity of the SARS-coronavirus ORF3. The present invention also relates to screening assays that identify agents which selectively inhibit the interaction between SARS-coronavirus cyclic-AMP dependent protein kinase and a calcium dependent targeting molecule. Therefore the agents identified using the assays of the invention may have utility as antiviral agents. The present invention also relates to treatments for sever acute respiratory syndrome caused by a coronavirus, and particularly to treatments that affect the infectivity activity of the SARS-coronavirus.Type: GrantFiled: May 17, 2005Date of Patent: March 17, 2009Assignee: The Burnham InstituteInventors: Adam Godzik, Sergey Sikora
-
Patent number: 7505256Abstract: The present invention relates to a device that provides privacy to a display. The invention works in conjunction with devices that are capable of being used in public. The display is typically part of an electronic apparatus, such as a laptop computer, portable DVD player, gaming machine and the like. The invention device includes at least a top panel and two side panels. The invention device also includes a gap bridging mechanism, which can be embodied in a variety of structures. The gap bridging mechanism bridges any gap formed between one or both side panels and the top panel resulting from the lateral or horizontal adjustment of these panels.Type: GrantFiled: June 8, 2006Date of Patent: March 17, 2009Inventor: Andrew Boudreau
-
Patent number: 7491176Abstract: A kit for obtaining an endoarterial biopsy sample from a patient including packaging material enclosing one or more kit components; the kit components include instruments use to perform a surgical procedure; and the kit includes separate phase specific packaging parts.Type: GrantFiled: November 1, 2001Date of Patent: February 17, 2009Assignee: Vascular BioSciencesInventor: David Marshall Mann
-
Patent number: 7442785Abstract: The invention relates to sesquiterpene synthases and methods for their production and use. Particularly, the invention provides nucleic acids comprising the nucleotide sequence of citrus valencene synthase (CVS) which codes for at least one CVS. The invention further provides nucleic acids comprising the nucleotide sequence coding for amino acid residues forming the tier 1 and tier 2 domains of CVS. The invention also provides for methods of making and using the nucleic acids and amino acids of the current invention.Type: GrantFiled: July 26, 2004Date of Patent: October 28, 2008Assignee: The University of Kentucky Research FoundationInventors: Joe Chappell, Brian Greenhagen
-
Patent number: 7416746Abstract: A new method is described for the treatment of cancer. In one alternative, the method utilizes two main compositions. The first composition is Soma, a healing herb described in the Rig Veda, the sacred scriptures of the Hindus. The second composition is a composite of plant-derived substances and a mineral. When they are administered to cancer patients following the recommended therapeutic regimen, regression of the cancer results. Alternatively, the second composition can be used alone.Type: GrantFiled: January 26, 2007Date of Patent: August 26, 2008Inventors: Peter Grandics, Joe K. Holbrook, Sr.
-
Patent number: 7413754Abstract: The present invention relates to extracts from Cimicifuga species and particularly from Cimicifuga racemosa, which are suited for producing a ready-formulated drug for the selective treatment and/or prophylaxis of sexual hormone-related disorders of the uro-genital tract. The extracts in accordance with the invention are moreover suited for the treatment and/or prophylaxis of post-menopausal urinary bladder infections. They are furthermore indicated for the treatment of benign and malignant prostate hyperplasies.Type: GrantFiled: September 16, 2002Date of Patent: August 19, 2008Assignee: Bionorica AGInventors: Wolfgang Wuttke, Hubertus Jarry, Volker Christoffel, Barbara Spengler
-
Patent number: 7405057Abstract: The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.Type: GrantFiled: March 8, 2002Date of Patent: July 29, 2008Assignee: Board of Trustees of the University of KentuckyInventors: Joseph Chappell, Lyle F. Ralston
-
Patent number: 7364737Abstract: Human monoclonal antibodies and fragments thereof which bind, neutralize and provide passive immunotherapy to respiratory syncytial virus (RSV) antigenic subgroups A and B are disclosed. Also disclosed are diagnostic and immunotherapeutic methods of using the monoclonal antibodies as well as cell line producing the monoclonal antibodies.Type: GrantFiled: January 29, 2004Date of Patent: April 29, 2008Assignee: The Scripps Research InstituteInventors: Dennis R. Burton, Carlos F. Barbas, III, Robert M. Chanock, Brian R. Murphy, James E. Crowe, Jr.
-
Patent number: 7357947Abstract: One embodiment of the invention is demineralized bone putty composition comprises: (1) demineralized bone matrix (DBM); and (2) a lipid fraction selected from the group consisting of lecithin and a mixture of lecithin and triglycerides containing unsaturated fatty acids. The putty composition is moldable, biocompatible, slowly resorbable, insoluble in tissue fluids, and non-extrudable. The composition delivers a biologically active product to animals and humans that will enhance bone formation at sites where bone is lost, deficient, or present in suboptimal amounts. The composition can further comprise calcium, an antioxidant such as Vitamin E or Vitamin C, or a hydrophilic polymer such as methylcellulose, a methylcellulose derivative, carboxymethyl cellulose, or hydroxypropyl methylcellulose.Type: GrantFiled: April 11, 2003Date of Patent: April 15, 2008Assignee: Biomet, Inc.Inventor: Marcel E. Nimni
-
Patent number: 7347429Abstract: A tote device comprising a compartment for storing recreational equipment and a strategically located holding mechanism for the placing of weighty objects, wherein said strategically located holding mechanism is placed such that the weight of a weighty object is distributed to lessen the weight load borne by a user. The strategically located holding mechanism is preferably a platform attached outside of the compartment. When a weighty object is placed on the strategically located holding mechanism and the tote device is in position for transporting the recreational equipment to a remote location, the strategic placement of the weighty recreational equipment will act to reduce the weight burden borne by the user.Type: GrantFiled: March 11, 2005Date of Patent: March 25, 2008Assignee: California Diving Company, LLCInventor: Lorenzo Murillo
-
Patent number: D609968Type: GrantFiled: March 6, 2008Date of Patent: February 16, 2010Inventor: Paule Stern
-
Patent number: D621615Type: GrantFiled: November 11, 2009Date of Patent: August 17, 2010Inventor: Mark Stern